Why the study?
Off-label medicine use is common in pediatric anesthesia due to limited approved drugs and trials, which may increase adverse events and litigation risk.
Provides principles and recommendations for anesthesia practitioners regarding the rational and clinically appropriate off-label use of medicines in pediatric patients.
Guides rational off-label prescribing in pediatric anesthesia now; extends benefit-risk principles to populations with sparse trial data.
BACKGROUND: Off-label medicine use is the administration of a medication in any manner that is not included in the approved package insert for that medication. The off label use of medicines is common in pediatric anesthesia due to the limited number of drugs that are specifically approved for use in children. This is due to the lack of clinical drug trials involving children, resulting in the absence of safety and efficacy data for this population of patients. This may lead to an increased risk of adverse events when these medicines are used in pediatric patients and expose anesthesia practitioners to the risk of litigation. AIMS: This paper describes an approach and principles for decision making for anesthesia practitioners around use of medicines in pediatric patients undergoing anesthesia. CONCLUSION: The decision to use a medication off label should be rational, clinically appropriate and based on a balance of benefit versus risk.
No takes yet. Share an insight, caveat, or question.
Lane et al. (2026) conducted a review in Pediatric anesthesia. Off-label medicine use was evaluated. The decision to use a medication off-label in pediatric anesthesia should be rational, clinically appropriate, and based on a balance of benefit versus risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: